10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-14-068523`
Period End Date	20140930
Filing Date	20141114
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	ameh-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 83 Cash Flow Statement 81 Stockholders Equity 15

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.08M	USD	Point-in-time
Marketable securities	`MarketableSecurities`	$422.18K	USD	Point-in-time
Marketable securities	`MarketableSecurities`	-	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$40.00K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.13M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.37M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.13M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.13M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.13M	shares	Point-in-time
Other receivable	`AccountsAndOtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivable	`AccountsAndOtherReceivablesNetCurrent`	$5.38M	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$24.04K	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$49.38K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$42.20K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$145.11K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.43M	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$324.00K	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$366.29K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$94.95K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$620.04K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$1.21M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.63K	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Goodwill	`Goodwill`	$439.69K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$108.75K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.64K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$16.06M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.48M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.45M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.79M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$552.56K	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.64M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$444.76K	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$304.76K	USD	Point-in-time
Holdback consideration	`HoldbackConsideration`	-	USD	Point-in-time
Holdback consideration	`HoldbackConsideration`	$136.82K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.88M	USD	Point-in-time
Notes payable, net of discount - non-current portion	`LongTermNotesPayable`	$5.34M	USD	Point-in-time
Notes payable, net of discount - non-current portion	`LongTermNotesPayable`	$5.34M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$962.98K	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$1.95M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.75M	USD	Point-in-time
Conversion feature liability	`ConversionFeatureLiability`	$-547.78K	USD	Point-in-time
Conversion feature liability	`ConversionFeatureLiability`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$89.79K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$16.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.11M	USD	Point-in-time
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS (NOTES 10 AND 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS (NOTES 10 AND 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 49,134,549 shares issued and outstanding as of September 30, 2014 and March 31, 2014, respectively	`CommonStockValue`	$49.13K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 49,134,549 shares issued and outstanding as of September 30, 2014 and March 31, 2014, respectively	`CommonStockValue`	$49.13K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$15.08M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.19M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$33.09K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.35M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.22M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-375.77K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-408.07K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-128.25K	USD	Point-in-time
Total	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Total	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-504.02K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$16.06M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$9.48M	USD	Point-in-time

Income Statement 83 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$2.52M	USD	1 Quarter
Net revenues	`Revenues`	$11.67M	USD	1 Quarter
Net revenues	`Revenues`	$5.14M	USD	2 Qtrs
Net revenues	`Revenues`	$15.76M	USD	2 Qtrs
Cost of services	`CostOfServices`	$4.72M	USD	2 Qtrs
Cost of services	`CostOfServices`	$2.26M	USD	1 Quarter
Cost of services	`CostOfServices`	$6.16M	USD	1 Quarter
Cost of services	`CostOfServices`	$9.42M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.45M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.04M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.97M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.46M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$193.28K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.53K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.88K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$205.18K	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$7.69M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$9.81M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$3.31M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$15.09M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$1.86M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-2.56M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$671.88K	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-786.62K	USD	1 Quarter
Interest expense	`InterestExpense`	$606.12K	USD	2 Qtrs
Interest expense	`InterestExpense`	$200.56K	USD	1 Quarter
Interest expense	`InterestExpense`	$329.26K	USD	1 Quarter
Interest expense	`InterestExpense`	$362.25K	USD	2 Qtrs
Gain on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	2 Qtrs
Gain on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$152.14K	USD	1 Quarter
Gain on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Gain on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$122.14K	USD	2 Qtrs
Other	`OtherNonoperatingIncome`	$6.44K	USD	1 Quarter
Other	`OtherNonoperatingIncome`	$-58.44K	USD	1 Quarter
Other	`OtherNonoperatingIncome`	$7.49K	USD	2 Qtrs
Other	`OtherNonoperatingIncome`	$-60.91K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-235.55K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-354.76K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-194.12K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-544.90K	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.62M	USD	1 Quarter
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$126.97K	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.91M	USD	2 Qtrs
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-980.74K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$800.00	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$86.99K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$98.59K	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.54M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-980.74K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-2.91M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$28.38K	USD	2 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$329.81K	USD	2 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$159.61K	USD	1 Quarter
Net income (loss) attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-980.74K	USD	1 Quarter
Net income (loss) attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-301.43K	USD	2 Qtrs
Net income (loss) attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-2.91M	USD	2 Qtrs
Net income (loss) attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$1.38M	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$33.09K	USD	2 Qtrs
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.50K	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.91M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-268.34K	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-980.74K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$1.39M	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$-0.08	USD	2 Qtrs
BASIC	`EarningsPerShareBasic`	$-0.03	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$0.03	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
DILUTED	`EarningsPerShareDiluted`	$0.03	USD	1 Quarter
DILUTED	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
DILUTED	`EarningsPerShareDiluted`	$-0.08	USD	2 Qtrs
DILUTED	`EarningsPerShareDiluted`	$-0.03	USD	1 Quarter
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	37.26M	shares	2 Qtrs
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	36.35M	shares	1 Quarter
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	49.13M	shares	1 Quarter
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	49.13M	shares	2 Qtrs
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	49.13M	shares	2 Qtrs
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.39M	shares	1 Quarter
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.35M	shares	1 Quarter
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.26M	shares	2 Qtrs

Cash Flow Statement 81 line items

Line Item	Tag	Value	Unit	Period
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$620.96K	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.54M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-980.74K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-2.91M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$28.38K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$193.28K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$6.53K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$12.88K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$205.18K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$59.31K	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$975.66K	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$856.52K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$568.71K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.12M	USD	2 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$62.28K	USD	2 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$4.30K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$177.96K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$116.25K	USD	2 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	2 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$152.14K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$122.14K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$993.67K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-323.86K	USD	2 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	$5.38M	USD	2 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-42.38K	USD	2 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-17.71K	USD	2 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-15.29K	USD	2 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$14.17K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$347.00	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$4.10K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-6.28K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.17M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-668.78K	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	-	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-312.68K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.12M	USD	2 Qtrs
Acquisitions, net of $620,960 in cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.95M	USD	2 Qtrs
Acquisitions, net of $620,960 in cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$248.80K	USD	2 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.22K	USD	2 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.58K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.96M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-251.02K	USD	2 Qtrs
Issuance of convertible note payable	`IssuanceOfConvertibleNotePayable`	$2.00M	USD	2 Qtrs
Issuance of convertible note payable	`IssuanceOfConvertibleNotePayable`	-	USD	2 Qtrs
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$-55.23K	USD	2 Qtrs
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$726.08K	USD	2 Qtrs
Contribution by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	2 Qtrs
Contribution by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	$550.00K	USD	2 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$240.00K	USD	2 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$600.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromSubscribedCommonStock`	$-728.75K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromSubscribedCommonStock`	-	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$20.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.20M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$543.99K	USD	2 Qtrs
NET DECREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-19.71K	USD	2 Qtrs
NET DECREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.88M	USD	2 Qtrs
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.08M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.08M	USD	Point-in-time
Interest paid	`InterestPaid`	$356.20K	USD	2 Qtrs
Interest paid	`InterestPaid`	$169.80K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$38.36K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$18.59K	USD	2 Qtrs
Acquisition related holdback liability consideration	`AcquisitionRelatedHoldbackLiabilityConsideration`	$136.82K	USD	2 Qtrs
Acquisition related holdback liability consideration	`AcquisitionRelatedHoldbackLiabilityConsideration`	-	USD	2 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	$487.62K	USD	2 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	$13.32K	USD	2 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$578.15K	USD	2 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$125.00K	USD	2 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$101.82K	USD	2 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$132.00K	USD	2 Qtrs

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-504.02K	USD	Point-in-time
Net income	`ProfitLoss`	$1.54M	USD	1 Quarter
Net income	`ProfitLoss`	$-980.74K	USD	1 Quarter
Net income	`ProfitLoss`	$-2.91M	USD	2 Qtrs
Net income	`ProfitLoss`	$28.38K	USD	2 Qtrs
Issuance of warrants	`IssuanceOfWarrants`	$132.00K	USD	2 Qtrs
Contribution by non-controlling interest	`ContributionByNoncontrollingInterest`	$550.00K	USD	2 Qtrs
Distribution to non-controlling interest	`DistributionToNonControllingInterest`	$-600.00K	USD	2 Qtrs
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$33.09K	USD	2 Qtrs
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.50K	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$975.66K	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-504.02K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.